The National Guideline Clearinghouse has published updates to the Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
GINA contains information about the diagnosis, evaluation, management and treatment of asthma. This guideline is often used as the standard in drug trials for asthma medication.
GOLD contains information about the diagnosis, classification, management and treatment of chronic obstructive pulmonary disease (COPD). This guideline is also often used as the standard in drug trials for COPD medication.
In the UK equivalent guidelines are produced for Asthma and COPD. The Asthma Guideline is produced by the British Thoracic Society and Scottish Intercollegiate Guidelines Network and the COPD Guideline by the National Institute for Health and Clinical Excellence.
Action: Clinicians should continue to implement the BTS/SIGN Asthma and NICE COPD guidelines. GINA and GOLD may provide additional information to those with a particular interest in asthma or COPD.
|« SMC reject rimonobant||Antibiotics cause resistance »|